Fact versus artifact: avoiding erroneous estimates of sulfated glycosaminoglycan content using the dimethylmethylene blue colorimetric assay for tissue-engineered constructs.
Zheng CH., Levenston ME.
Animal Study on Meniscus Injury, published in Eur Cell Mater (2015) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Eur Cell Mater (2015)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 25890595
- DOI
- 10.22203/ecm.v029a17
Abstract (original English)
The 1,9-dimethylmethylene blue (DMMB) assay is widely used to quantify sulfated glycosaminoglycan (sGAG) contents of engineered tissues, culture media, tissue samples and bodily fluids, but the assay is subject to interference from polyanions such as hyaluronic acid (HA), DNA and RNA. We examined whether specific combinations of dye pH and absorbance wavelength could minimize non-sGAG artifacts without compromising DMMB assay sensitivity. HA and DNA solutions generated substantial signal at pH 3 but not at pH 1.5. Reducing dye pH did not significantly alter sGAG measurements for normal cartilage and meniscus tissues, but eliminated anomalously high apparent sGAG contents for enzymatically isolated chondrocytes, adipose-derived stem cell (ADSC)-agarose constructs and ADSC pellets. In a cartilage tissue-engineering case study, pH 3 dye indicated high apparent sGAG readings throughout culture in both basal and chondrogenic media, with a marked decline between day 14 and 21 for chondrogenic constructs. The pH 1.5 dye, however, indicated minimal sGAG accumulation in basal medium and stable sGAG content throughout culture in chondrogenic medium. As it is often difficult to know a priori whether all groups in a study will have sGAG contents high enough to overwhelm artifacts, we recommend modifying the standard DMMB assay to reduce the risk of spurious findings in tissue engineering a
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Optimizing Meniscus Allograft Transplantation - Reducing Extrusion and Restoring Joint Loading Mechanics: A Systematic Review
Systematic Review on Osteoarthritis, Meniscus Injury, published in Curr Rev Musculoskelet Med (2026) — summary generated from the PubMed abstract.
- 2026
Curr Rev Musculoskelet Med - Level ASystematic ReviewEurope PMC
Emerging biologic augmentation strategies for meniscal repair: a systematic review
Systematic Review with a reported sample of 18 on Meniscus Injury, Chronic Wound, published in BMC Musculoskelet Disord (2024) — summary generated from the PubMed abstract.
- 2024
- n = 18
BMC Musculoskelet Disord7 citations - Level ASystematic ReviewEurope PMC
Osteoarthritis After Anterior Cruciate Ligament Reconstruction: A Systematic Review of Contributing Factors and Potential Treatments
Systematic Review on Osteoarthritis, Meniscus Injury, Ligament Injury, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus1 citations - Level ASystematic ReviewPubMed
Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies.
Systematic Review on Osteoarthritis, Meniscus Injury, published in Knee Surg Sports Traumatol Arthrosc (2022) — summary generated from the PubMed abstract.
- 2022
Knee Surg Sports Traumatol Arthrosc40 citations - Level ASystematic ReviewPubMed
Cell-based therapy in soft tissue sports injuries of the knee: a systematic review.
Systematic Review with a reported sample of 9 on Osteoarthritis, Meniscus Injury, Tendon Injury, Ligament Injury, published in Expert Opin Biol Ther (2021) — summary generated from the PubMed abstract.
- 2021
- n = 9
Expert Opin Biol Ther10 citations - Level ASystematic ReviewPubMed
Stem cells application in meniscal tears: a systematic review of pre-clinical and clinical evidence.
Systematic Review on Meniscus Injury, published in Eur Rev Med Pharmacol Sci (2021) — summary generated from the PubMed abstract.
- 2021
Eur Rev Med Pharmacol Sci